These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6084527)

  • 1. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM; Strange PG
    Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the prostacyclin receptor by radiation inactivation.
    Leigh PJ; Cramp WA; MacDermot J
    J Biol Chem; 1984 Oct; 259(20):12431-6. PubMed ID: 6208187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internalization and down-regulation of the prostacyclin receptor in human platelets.
    Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors.
    Leigh PJ; MacDermot J
    Br J Pharmacol; 1985 May; 85(1):237-47. PubMed ID: 2992650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid.
    Blair IA; MacDermot J
    Br J Pharmacol; 1981 Mar; 72(3):435-41. PubMed ID: 6266565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.
    Kelly E; Keen M; Nobbs P; MacDermot J
    Br J Pharmacol; 1990 Feb; 99(2):309-16. PubMed ID: 1691675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
    Fisch A; Tobusch K; Veit K; Meyer J; Darius H
    Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative prostacyclin receptor antagonist (FCE-22176) is a full agonist on human platelets and NCB-20 cells.
    Wilkins AJ; MacDermot J
    Eur J Pharmacol; 1986 Aug; 127(1-2):117-9. PubMed ID: 2428638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of selective [3H]iloprost binding sites on human platelet membranes.
    Steurer G; Jankovic B; Ettl K; Schernthaner G
    Prog Clin Biol Res; 1987; 242():25-34. PubMed ID: 2444987
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel subtype of the prostacyclin receptor expressed in the central nervous system.
    Takechi H; Matsumura K; Watanabe Y; Kato K; Noyori R; Suzuki M; Watanabe Y
    J Biol Chem; 1996 Mar; 271(10):5901-6. PubMed ID: 8621463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterisation of a prostacyclin-like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand.
    Town MH; Schillinger E; Speckenbach A; Prior G
    Prostaglandins; 1982 Jul; 24(1):61-72. PubMed ID: 6181535
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization of prostacyclin receptors in a neuronal hybrid cell line.
    Blair IA; Leigh PJ; MacDermot J
    Br J Pharmacol; 1982 Sep; 77(1):121-7. PubMed ID: 6289953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalent cations increase [3H]-prostacyclin binding to membranes of neuronal somatic hybrid cells.
    Blair IA; Cresp TM; MacDermot J
    Br J Pharmacol; 1981 Jul; 73(3):691-4. PubMed ID: 7018637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished inhibition of adhesion molecule expression in prostacyclin receptor desensitized human platelets.
    Darius H; Veit K; Binz C; Fisch A; Meyer J
    Agents Actions Suppl; 1995; 45():77-83. PubMed ID: 7536385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H; Binz C; Veit K; Fisch A; Meyer J
    J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.